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ABSTRACT
Background. The microbiota in the small intestine relies on their capacity to rapidly
import and ferment available carbohydrates to survive in a complex and highly
competitive ecosystem. Understanding how these communities function requires
elucidating the role of its key players, the interactions among them and with their
environment/host.
Methods. The genome of the gut bacterium Romboutsia ilealis CRIBT was sequenced
withmultiple technologies (Illumina paired-end,mate-pair and PacBio). The transcrip-
tome was sequenced (Illumina HiSeq) after growth on three different carbohydrate
sources, and short chain fatty acids were measured via HPLC.
Results. We present the complete genome of Romboutsia ilealis CRIBT, a natural
inhabitant and key player of the small intestine of rats. R. ilealis CRIBT possesses a
circular chromosome of 2,581,778 bp and a plasmid of 6,145 bp, carrying 2,351 and
eight predicted protein coding sequences, respectively. Analysis of the genome revealed
limited capacity to synthesize amino acids and vitamins, whereas multiple and partially
redundant pathways for the utilization of different relatively simple carbohydrates are
present. Transcriptome analysis allowed identification of the key components in the
degradation of glucose, L-fucose and fructo-oligosaccharides.
Discussion. This revealed that R. ilealis CRIBT is adapted to a nutrient-rich environ-
ment where carbohydrates, amino acids and vitamins are abundantly available.
Subjects Genomics, Microbiology
Keywords Romboutsia, Functional genomics, RNAseq, Gut, Microbiome, Small intestine,
Probiotics, Prebiotics
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INTRODUCTION
Intestinal microbes live in a complex and dynamic ecosystem, and to survive in this highly
competitive environment, they have developed close (symbiotic) associations with a diverse
array of other intestinal microbes and with their host. This has led to a complex network
of host-microbe and microbe-microbe interactions in which the intestinal microbes and
the host co-metabolise many substrates (Backhed et al., 2005; Scott et al., 2013). In addition
to competition for readily available carbohydrates in the diet, intestinal microbes are able
to extract energy from dietary polysaccharides that are indigestible by the host (Flint et al.,
2012). Furthermore, intestinal microbes can utilize host-derived secretions (e.g., mucus)
as substrates for metabolic processes (Ouwerkerk, De Vos & Belzer, 2013). In turn, the
metabolic activities of the intestinal microbes result in the production of a wide array of
compounds, of which some are important nutrients for the host. For example, short chain
fatty acids (SCFA), the main end-products of bacterial fermentation in the gut, can be
readily absorbed by the host and further metabolized as energy sources (Elia & Cummings,
2007; Lange et al., 2015). All together, the metabolic activity of the intestinal microbiota has
a major impact on the health of the host, and recent studies have indicated an important
role for microbial activity in diseases such as inflammatory bowel disease, irritable bowel
syndrome and obesity (Gerritsen et al., 2011a; Quigley, 2013).
We only have a limited understanding of the heterogeneity in microbial community
composition and activity in different niches along the length of the intestinal tract. To
unravel the functional contribution of specific intestinal microbes to host physiology and
pathology, we have to understand their metabolic capabilities at a higher resolution. It is
still difficult, however, to associate a functionality in this ecosystem to specific sets of genes
and in turn to individual microbial species, and vice versa. To this end, the combination of
genome mining and functional analyses with single microbes or with simple and defined
communities can provide an overall insight in the genetic and functional potential of
specific members of the intestinal microbial community (Heinken et al., 2013; Li et al.,
2008; Xu et al., 2003).
As mentioned above, intestinal microbes have adapted or even specialized in foraging
certain niche-specific substrates. However, little is known about the adaption of intestinal
microbes to the conditions in the small intestine (Booijink et al., 2007; Van den Bogert et
al., 2013b; Zhang et al., 2014). Community composition and activity in the small intestine
is largely determined by the host digestive fluids such as gastric acid, bile and pancreatic
secretions. The small intestine is a nutrient-rich environment, and previous studies have
shown that the microbial communities in the (human) small intestine are driven by the
rapid uptake and conversion of simple carbohydrates (Zoetendal et al., 2012; Leimena et
al., 2013). Genomic studies of small intestinal isolates have indicated environment-specific
adaptations to the small intestine with respect to their carbohydrate utilization capacities,
which was evidenced by the presence of a wide array of genes involved in nutrient transport
and metabolism of, mainly simple, carbohydrates (Van den Bogert et al., 2013a).
Here we describe a model driven genomic analysis of the small intestinal inhabitant
Romboutsia ilealis CRIBT (Gerritsen et al., 2014). R. ilealis CRIBT is currently still the
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only isolate of the recently descibed species R. ilealis, a species that belongs to the family
Peptostreptococcaceae, of which many members are common intestinal microbes including
the well-known species Clostridioides difficile (previously known as Clostridium difficile)
and Intestinibacter bartlettii (previously known as Clostridum bartlettii) (Galperin et al.,
2016). An overview of the metabolic capabilities and nutritional potential of the type
strain of R. ilealis CRIBT is provided here to identify potential mechanisms that enable this
organism to survive in the competitive small intestinal environment.
MATERIALS AND METHODS
Genome sequencing, assembly and annotation
R. ilealis CRIBT (DSM 25109) was routinely cultured in CRIB medium at 37 ◦C as
previously described (Gerritsen et al., 2014). Genomic DNA extraction was performed as
previously described (Van den Bogert et al., 2013a). Genome sequencingwas done using 454
Titanium pyrosequencing technology (Roche 454 GS FLX), as well as Illumina (Genome
Analyzer II and HiSeq2000) and PacBio sequencing (PacBio RS). Mate-pair data was
generated by BaseClear (Leiden, the Netherlands). All other data was generated by GATC
Biotech (Konstanz, Germany). The genome was assembled in a hybrid approach with
multiple assemblers. In short, after estimation of the genome size, assembly of the genome
was performed with two different assemblers in parallel using the different sequence
datasets. After merging the two assemblies three rounds of scaffolding were performed,
once with paired-end data and twice with mate-pair data. Gap-filling was performed after
each scaffolding step.
Genome annotationwas carried out with an in-house pipeline. Prodigal v2.5 was used for
prediction of protein codingDNA sequences (CDS) (Hyatt et al., 2010), InterProScan 5RC7
for protein annotation (Hunter et al., 2012), tRNAscan-SE v1.3.1 for prediction of tRNAs
(Lowe & Eddy, 1997) and RNAmmer v1.2 for the prediction of rRNAs (Lagesen et al., 2007).
Additional protein function predictions were derived via BLAST identifications against
the UniRef50 (Suzek et al., 2007) and Swissprot (UniProt-Consortium, 2014) databases
(download August 2013). Afterwards the annotation was further enhanced by adding EC
numbers via PRIAM version March 06, 2013 (Claudel-Renard et al., 2003). Non-coding
RNAs were identified using rfam_scan.pl v1.04, on release 11.0 of the RFAM database
(Burge et al., 2013). CRISPRs were annotated using CRISPR Recognition Tool v1.1 (Bland
et al., 2007).
Qualitative metabolic modelling has been performed with Pathway tools v18.0
(Latendresse et al., 2012). A generic default medium consisting out of ammonia/urea,
sulfite, hydrogen sulfide and phosphate was assumed, and the qualitative possibility
to produce all necessary biomass metabolites was tested with the supply of different
carbohydrates, which had been tested before in vitro.
See the Supplemental Methods in Text S1 for details on the genomic DNA extraction,
genome sequencing, assembly, annotation, and metabolic modelling.
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Whole-genome transcriptome analysis
R. ilealis CRIBT was grown in a basal bicarbonate-buffered medium (Stams et al., 1993)
supplemented with 16 g/L yeast extract (BD, Breda, The Netherlands) and an amino
acids solution as used for the growth of C. difficile (Karasawa et al., 1995). In addition,
the medium was supplemented with either 0.5% (w/v) D-glucose (Fisher Scientific
Inc., Waltham, MA USA), L-fucose (Sigma-Aldrich, St. Louis, MO, USA) or fructo-
oligosaccharide (FOS) P06 (DP 2-4; Winclove Probiotics, Amsterdam, The Netherlands).
The final pH of the medium was adjusted to 7.0. For each condition, triplicate cultures
were set up. For RNA-seq analysis, the cells were harvested in mid-exponential phase
(OD600 nm = 0.25–0.55, ∼8–10 h incubation) (Table S1).
Total RNAwas purified using the RNeasyMini Kit (QIAGENGmbH,Hilden, Germany).
Depletion of rRNA was performed using the Rib-ZeroTM Kit for bacteria (Epicentre
Biotechnologies, Madison, WI, USA). The ScriptSeqTM v2 RNA-seq Library Preparation
Kit in combination with ScriptSeqTM Index PCR primers (Epicentre Biotechnologies)
was used for library construction for whole-transcriptome sequencing (RNA-seq). The
barcoded cDNA libraries were pooled and sent to GATC Biotech (Konstanz, Germany)
where 150 bp sequencing was performed on one single lane using the Illumina HiSeq2500
platform in combination with the TruSeq Rapid SBS (200 cycles) and TruSeq Rapid
SR Cluster Kits (Illumina Inc., San Diego, CA, USA). Reads were mapped to the genome
with Bowtie2 v2.0.6 (Langmead & Salzberg, 2012) using default settings, after quality
control (rRNA removal, adapter trimming, and quality trimming) had been performed.
Details on the RNA-seq raw data analysis can be found in Table S2 and Supplemental
Methods in Text S1.
Gene expression abundance estimates and differential expression analysis was performed
using Cuffdiff v2.1.1 (Trapnell et al., 2013) with default settings. Differentially expressed
genes were determined by pairwise comparison of a given condition to the other three
conditions for a total of six pairwise comparisons. Genes were considered significantly
differentially expressed when they showed a≥1.5 log2 (fold change) in any of the conditions
with a false discovery rate (FDR)-corrected P value (q value) ≤ 0.05 (Tables S3–S6).
Principal component analysis was performed with Canoco 5.0 (Ter Braak & Smilauer,
2012) on log-transformed gene transcript abundances using Hellinger standardization.
Gene expression heatmaps were generated based on gene transcript abundances using R
v3.1.0 and R-packages svDialogs and gplots.
See the SupplementalMethods in Text S1 for details on growth on different carbohydrate
media and whole genome transcriptome analysis.
Metagenomic investigations
The datasets PRJNA237362 (Gevers et al., 2014) and PRJNA298762 (Alipour et al., 2016)
were analysed as relevant representative publicly available 16s rRNA gene amplicon datasets
for the presence of 16S rRNA gene sequences closely related to that ofR. ilealiswith NG-Tax
version 0.3 (Ramiro-Garcia et al., 2016) with the–classifyRatio argument set to 0.9.
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Table 1 General features of the R. ilealis CRIBT genome.
Chromosome Plasmid
Size (bp) 2,581,778 6,145
G+ C content (%) 27.9 29.3
Protein CDS 2,351 8
Pseudogenes 12 0
Coding density 1.10 1.02
Average gene size (bp) 899 531
rRNA genes
16S rRNA genes 14 0
23S rRNA genes 14a 0
5S rRNA genes 14 0
tRNAs 109 0
ncRNAs 28 0
CRISPR repeats 1a71 0
Notes.
aAn additional 23S rRNA gene is expected in one of the gaps.
Nucleotide sequence accession number
All related data have been deposited in the European Nucleotide Archive. The raw
reads for the genome of R. ilealis CRIBT can be accessed via the accession numbers
ERR366773, ERX397233, ERX397242 and ERX339449. The assembly can be accessed
under LN555523–LN555524. The RNAseq data have been deposited under the numbers
ERS533849–ERS533860.
RESULTS
Genome analysis
Global genome features
R. ilealis CRIBT contains a single, circular chromosome of 2,581,778 bp and a plasmid of
6,145 bp (Table 1 and Fig. 1). The chromosome contains 2,351 predicted protein CDS, of
which 321 were annotated as hypothetical and for 91, only a domain of unknown function
could be assigned. The plasmid carries eight predicted protein CDS, of which none was
recognized for having a metabolic or replicative function. Furthermore, it appears to be
a non-mobilizable plasmid, given that it lacks any known mobilization-associated genes.
The overall G + C content of the genome is 27.9%, which is in good agreement with a G
+ C content of 28.1 mol% previously determined for R. ilealis CRIBT by HPLC methods
(Gerritsen et al., 2014).
With a total of 14 copies of the 16S ribosomal RNA (rRNA) gene, R. ilealis CRIBT is
among the species with the highest number of 16S rRNA gene copies reported up to this
date (Lee, Bussema & Schmidt, 2009). High numbers of rRNA operons have been proposed
to be indicative for fast growth and to allow microbes to respond quickly to changes
in available resources (Klappenbach, Dunbar & Schmidt, 2000). In addition, a high copy
number of the rRNA operon has been suggested to be essential for successful sporulation
and germination (Yano et al., 2013). This is also reflected in the observation that in general
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Urease cluster
CRISPR‐CAS system
Choloylglycine hydrolase
Fucose degrada�on cluster
Sucrose degrada�on cluster #1
Sucrose degrada�on
cluster #2
Figure 1 Circular map of the R. ilealis CRIBT genome. Both chromosome and non-mobilizable plasmid
are shown. For the chromosome tracks from inside to outside are as follows: 1, GC skew; 2, G+ C con-
tent; 3, RNAs [rRNAs (blue), tRNAs (orange) and ncRNAs (purple)]; 4, all predicted protein CDS [with
predicted function (light-blue), hypothetical proteins and proteins to which only a domain of unknown
function could be assigned (grey)]; 5, genes or gene clusters of interest [(mobile genetic elements (red),
Cas proteins (pink), urease gene cluster (yellow), choloylglycine hydrolase (black), gene clusters involved
in carbohydrate utilization (green)]. For the plasmid tracks from inside to outside are as follows: 1, GC
skew; 2, G+ C content; 3, all predicted CDS.
the species that contain the highest number of reported rRNA operons, including R. ilealis
CRIBT, belong to the spore-forming bacterial orders Bacillales and Clostridiales. Not all of
the 16S rRNA gene copies in R. ilealis CRIBT are embedded in the conserved 16S-23S-5S
rRNA operon structure. Of the fifteen locations containing rRNA genes, ten are in the
classical order 16S-23S-5S. The other five operons are characterized by duplicated or
missing rRNA genes, or a different order of the genes. It should be noted that the current
assembly contains three gaps, all of which are located within rRNA operons. Diverging
rRNA operon structures have been reported for other genomes containing multiple rRNA
operons, as a result of duplications (Bensaadi-Merchermek et al., 1995; Schwartz, Gazumyan
& Schwartz, 1992).
A cluster of orthologous genes (COG) category (Tatusov, Koonin & Lipman, 1997)
could be assigned to 1,647 of the predicted proteins (70%) including 372 proteins (16%)
assigned to the categories R (general function prediction only) and S (function unknown)
(Fig. S1).With InterProScan a predicted function could be assigned to 82% of the predicted
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proteins. Based on the InterPro and PRIAM classifications (Claudel-Renard et al., 2003),
an enzymatic function could be predicted for more than 500 proteins.
General metabolic pathways
Analysis of the CDS predicted from the R. ilealis CRIBT genome revealed the presence of
a complete set of enzymes for the glycolytic pathway. In line with the anaerobic lifestyle
of the organism, enzymes for the oxidative phase of the pentose phosphate pathway could
not be detected. Additionally, the genes that encode enzymes involved in the tricarboxylic
acid cycle were lacking. Subsequently a metabolic model was constructed with Pathway
tools v18.0. A flux balance analysis with the model was performed, suggesting that R. ilealis
CRIBT is a mixed acid fermenter as previously reported (Gerritsen et al., 2014). Predicted
end products of fermentation are a mixture of acetate, formate, lactate and ethanol, with
the possibility of gas formation (CO2 and H2). In addition to ethanol, which can be
produced during mixed acid fermentation, 1,2-propanediol was predicted to be formed
via the L-fucose degradation pathway. The fermentation end products formate, acetate
and lactate are predicted to be produced from pyruvate. No other solvents were predicted
to be produced by the metabolic model. The only metabolite produced by R. ilealis CRIBT
that was not accounted for by the metabolic model, was propionate. None of the three
established pathways for propionate production in the intestinal tract, i.e., the succinate,
acrylate or the propanediol pathway (Reichardt et al., 2014), could be identified at the
genetic level in the genome of R. ilealis CRIBT. Although propionate is only produced in
low amounts (max. 3 mM in 24 h) it is noteworthy because propionate production was
observed repeatedly during in vitro growth in this study (see Table 2) and as previously
reported (Gerritsen et al., 2014).
The analysis of the genome and the prediction by the model indicated that fermentation
is probably the main process for energy conservation in R. ilealis. However, the presence
of a sulfite reductase gene cluster (CRIB_1284-CRIB_1286) of the dissimilatory asrC-type
(Dhillon et al., 2005) points at possible anaerobic respiration. Similar siroheme-dependent
sulfite reductases are found in many close-relatives of R. ilealis such as I. bartlettii,
Clostridium sordellii andC. difficile (Czyzewski & Wang, 2012). Sulfite reduction byR. ilealis
CRIBT, and close relatives, has been previously demonstrated in vitro (Gerritsen et al., 2014),
and increased growth yield and metabolite production was observed in the presence of
sulfite for R. ilealis CRIBT (Table S7). In the intestinal tract, sulfite is derived from food
sources that contain sulfite as a preservative, and it has been shown that neutrophils
release sulfite as a part of the host defence against microbes (Mitsuhashi et al., 1998).
Metabolism of growth factors and cofactors
Complete pathways are present for the biosynthesis of the amino acids aspartate,
asparagine, glutamate, glutamine and cysteine, using carbon skeletons available from
central metabolites or via conversion of other amino acids. However, many genes encoding
enzymes required for biosynthesis of other amino acids appeared to be absent in R. ilealis
CRIBT. As most missing genes are part of well-studied pathways, it is unlikely these
functionalities are encoded by unknown genes and likely represent true auxotrophies. The
absence of genes to produce branched-chain amino acids (leucine, isoleucine and valine)
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Table 2 Fermentation end products of R. ilealis CRIBT produced during growth on different carbohydrates (glucose, FOS or L-fucose) or in basal medium in the ab-
sence of a carbon source (control condition). Samples were obtained during mid-exponential phase (∼8–10 h incubation; used for transcriptome analysis) and in sta-
tionary phase (24 h incubation). For the control cultures, fermentation products are shown for the individual cultures separating the carbohydrates used for precondition-
ing of the inoculum. For the three other conditions, values represent means of triplicate cultures with standard deviations.
Formate (mM) Acetate (mM) Propionate (mM) Lactate (mM) 1,2-propane-diol (mM)
8–10 h 24 h 8–10 h 24 h 8–10 h 24 h 8–10 h 24 h 8–10 h 24 h
Control: basal medium
(glucose inoc.) 3.2 7.7 2.0 6.2 2.0 2.2 N.D. N.D. N.D. N.D.
(FOS inoc.) 4.5 9.2 2.4 7.4 2.4 2.9 N.D. N.D. N.D. N.D.
(L-fucose inoc) 4.8 10.8 2.3 9.8 2.3 3.0 N.D. N.D. 1.0 1.0
Basal medium+ glucose
(5% w/v)
4.4± 1.2 28.2± 4.3 1.0± 0.9 16.3± 2.2 1.0± 0.9 1.3± 0.1 N.D. 3.0± 0.7 N.D. N.D.
Basal medium+ FOS
(5% w/v)
4.7± 0.6 27.3± 2.5 1.4± 0.0 17.7± 1.4 1.4± 0.0 1.6± 0.1 N.D 2.5± 0.3 N.D. N.D.
Basal medium+ L-fucose
(5% w/v)
6.7± 0.1 19.5± 3.6 2.8± 0.1 16.3± 2.9 2.8± 0.1 2.8± 0.4 N.D. N.D. 1.3± 0.1 7.7± 1.4
Notes.
N.D., not detected.
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was also reflected in the absence of branched chain fatty acids in the cell membrane of
R. ilealis, which is characteristic for the genus Romboutsia (Gerritsen et al., 2014). From
these observations it can be concluded that R. ilealis depends on a number of exogenous
amino acids, peptides and/or proteins to fuel protein synthesis. The dependency on an
exogenous source of amino acids is reflected by the identification of multiple amino
acid transporters, including an arginine/ornithine antiporter, multiple serine/threonine
exchangers, a transporter for branched amino acids, and several amino acid symporters and
permeases without a predicted specificity. Furthermore, numerous genes were annotated
as protease or peptidase, including several with a signal peptide.
R. ilealisCRIBT appears to contain all genes for de novo purine and pyrimidine synthesis,
as well as for the production of the coenzymes NAD and FAD via salvage pathways from
niacin and riboflavin, respectively. While some organic cofactors can be produced by
R. ilealis CRIBT, it mainly relies on salvage pathways (e.g., for lipoic acid) or exogenous
sources for the supply of precursors, mainly in the form of vitamins (e.g., thiamin,
riboflavin, niacin, pantothenate, pyridoxine, biotin, vitamin B12).
Carbohydrate transport and metabolism
As previously reported, R. ilealis CRIBT is able to utilize a wide variety of carbohydrates
(Gerritsen et al., 2014). Previously, good growth of R. ilealis on L-fucose, glucose, raffinose
and sucrose was described, in addition tomoderate growth onD-arabinose andD-galactose
andweak growth onD-fructose, inulin, lactose,maltose andmelibiose. Growth on L-fucose,
fructose, galactose, glucose, lactose, maltose, melibiose, raffinose and sucrose was predicted
from the genome-scale metabolic model as well. For these different carbohydrates, the
genes encoding the specific carbohydrate degradation enzymes were found distributed
throughout the genome in gene clusters together with their respective transporters and
transcriptional regulator. The only carbohydrate utilized by R. ilealis CRIBT that was
not predicted based on the metabolic model, was D-arabinose. Although a separate
arabinose transporter, similar to the maltose and sucrose transporters, could be identified
in the genome R. ilealis CRIBT, no separate pathway for the use of D-arabinose could be
predicted, However, it is likely that the L-fucose degradation pathway (encoded by genes
CRIB_1294-CRIB_1298) is also used for D-arabinose utilization as is also observed in
other intestinal species (LeBlanc & Mortlock, 1971). In addition to the carbohydrates for
which growth was studied, a gene cluster involved in the degradation of the host-derived
carbohydrate sialic acid could be predicted (CRIB_613-CRIB_619) (Almagro-Moreno &
Boyd, 2009). The structure of this gene cluster is similar to the one identified in C. difficile
(Ng et al., 2013). The ability to degrade the predominantly host-derived carbohydrates,
L-fucose and sialic acid, suggest a role in the utilization of mucin, an abundant host-derived
glycoprotein in the intestinal tract (Derrien et al., 2010; Ouwerkerk, De Vos & Belzer, 2013).
However, no growth on mucin was observed (Table S7), which is in line with the lack of a
predicted extracellular fucosidase and/or sialidase.
Other genes encoding niche-specific functionalities
A gene cluster encoding a urease, consisting of three subunits (ureABC), and a number of
urease accessory genes was identified (CRIB_1381-CRIB_1388). The gene cluster identified
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in R. ilealis CRIBT is very similar to the urease gene cluster in the genome of C. sordellii
(Fig. S3), a species in which the urease activity is used to phenotypically distinguish
C. sordellii strains from C. bifermentans strains (Roggentin et al., 1985). Furthermore, a
possible ammonium transporter (CRIB_1389) was identified in the genome of R. ilealis
CRIBT next to the urease gene cluster. Ureases are nickel-containing metalloenzymes that
catalyse the hydrolysis of urea to ammonia and carbon dioxide, and thereby these enzymes
allow microbes to use urea as nitrogen source by assimilation via glutamate. They are
ubiquitous proteins occurring in diverse organisms (Mobley, Island & Hausinger, 1995). In
the intestinal environment, where urea is abundantly present (Fuller & Reeds, 1998), some
bacteria use ureases to survive the acidic conditions in the upper part of the intestinal tract
as urea hydrolysis leads to a local increase in pH (Rutherford, 2014).
Another gene encoding a niche-specific functionality is the predicted choloylglycine
hydrolase. Proteins within the choloylglycine hydrolase family are bile salt hydrolases
(BSHs), also known as conjugated bile acid hydrolases (CBAHs), that are widespread
among intestinal microbes (Ridlon, Kang & Hylemon, 2006). They are involved in the
hydrolysis of the amide linkage in conjugated bile salts, releasing primary bile acids.
There is a large heterogeneity among BSHs, for example with respect to their substrate
specificity. The BSH of R. ilealis CRIBT was found to be the most similar to the one found
in Clostridium butyricum. Although the physiological advantages of BSHs for the microbes
are not completely understood, it has been hypothesized that they constitute a mechanism
to detoxify bile salts and thereby enhance bacterial colonization (Czyzewski & Wang, 2012).
Metabolite and transcriptome analysis
Metabolite and transcriptome analysis of R. ilealis CRIBT during growth on
different carbohydrates
To study key pathways predicted to be involved in carbohydrate utilization and their
regulation in more detail, a genome-wide transcriptome analysis was performed, focussing
on four experimental conditions. Firstly, growth on glucose, a preferred substrate for many
microbes present in the intestinal tract, was studied. Secondly the growth on fructans, oligo-
and polysaccharides present in many food items was examined. Previously weak growth
on inulin, a polysaccharide consisting of long chains of β1→ 2 linked fructose units, was
observed (Gerritsen et al., 2014). For this study a shorter fructan (FOS P06, DP2-4) was
chosen, because growth on shorter fructans is likely more relevant for microbes living in
the small intestine (Zoetendal et al., 2012). Thirdly, growth on L-fucose was examined, as
growth on this substrate was found to be unique for R. ilealis CRIBT compared to other
related microbes. Finally, R. ilealis CRIBT was also grown in the basal medium in the
absence of an additional carbon source for comparison (control condition).
Based onmeasurements of optical density and pH during growth (growth characteristics
of individual cultures can be found inTable S1), samples were drawn in themid-exponential
phase (∼8–10 h incubation; used for transcriptome analysis) and in stationary phase (24 h
incubation), and sugar utilization and fermentation products were measured with HPLC
(Table 2). In neither of the experimental conditions the supplied carbohydrates were
depleted, and metabolites were still produced at the time of sampling at∼8–10 h and 24 h,
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which further confirmed that samples obtained for transcriptome analysis at∼8–10 h were
taken during exponential growth. In the FOS cultures, an accumulation of extra-cellular
fructose was observed. As predicted from the metabolic model, growth on glucose resulted
in the production of formate, acetate and lactate (Table 2).
Growth on FOS was marginally lower than that on glucose, however, after 24 h of
growth, the same fermentation products were observed in similar amounts (Table 2).
Growth on L-fucose showed production of 1,2-propanediol instead of lactate. The fact that
1,2-propanediol was observed in one of the control cultures could be explained by the fact
that an L-fucose grown culture was used as inoculum for this culture, leading to carry-over
of minor amounts of metabolites.
For the genome-wide transcriptome analysis of triplicate cultures grown in the four
different conditions (i.e., a total of 12 cultures), a total of 159,250,634 150 bp-readswere gen-
erated by RNA-seq (overview in Table S2). Principal component analysis of the transcrip-
tomes of the individual cultures showed that the cultures clustered by condition (Fig. 2).
Differential expression of genes involved in carbohydrate degradation and
fermentation in R. ilealis CRIBT
To identify differentially regulated genes, pairwise comparisons were done with cuffdiff
(Trapnell et al., 2013) using a cut off of≥1.5 log2 (fold-change) and q-value≤ 0.05. Figure 3
shows a heat map of all differentially regulated genes, and exact numbers can be found in
Tables S3–S6.
The gene cluster involved in glycolysis (CRIB_186-CRIB_191) was most abundantly
expressed in the conditions that support the highest growth rates determined by the highest
cell density reached in the time period that wasmeasured (glucose, followed by FOS; Fig. 3).
This was also reflected in the fact that expression of genes encoding proteins involved in
replication such as ribosomal proteins, proteins involved in cell wall biosynthesis and
general cell division processes were most strongly expressed during growth in the presence
of glucose and to a lesser extent FOS. Other genes involved in the central sugar metabolic
pathways (e.g., CRIB_1849, CRIB_140, CRIB_2223, and CRIB_105) were upregulated in
these conditions, albeit not significantly differentially regulated. This suggests that these
genes are less tightly regulated at the transcriptional level, probably because they are also
involved in other processes than sugar degradation (Commichau et al., 2009). Themetabolic
model suggests that this is indeed the case, as some of the enzymes produce intermediates
which can be consumed by fatty acid biosynthesis and amino acid biosynthesis processes.
Altogether, the transcriptome of R. ilealis CRIBT grown on FOS was very similar to its
transcriptome when grown on glucose (Fig. 2), with only 18 genes significantly upregulated
during growth in the presence of FOS compared to glucose (Table S4). Apparent was the
upregulation of the gene clusters that code for proteins involved in the transport and
degradation of the respective sugars or their derivatives (Fig. 3). In the presence of glucose,
the glucose-specific PTS system (CIRB_2017-CRIB_2018) was significantly upregulated,
together with its associated transcriptional regulator (CRIB_2019). In turn, in the presence
of FOS, two clusters predicted to be involved in sucrose degradation (CRIB_148-CRIB_152
and CRIB_1458-1461) were significantly upregulated. The third gene cluster predicted to
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Figure 2 Principal component analysis of the transcriptomes of R. ilealis CRIBT grown on different
carbohydrates (glucose, FOS and L-fucose) or in the absence of an additional carbon source (control).
First and second ordination axes are plotted, explaining 42.8% and 19.0% of the variability in the data set,
respectively. Individual transcriptomes are symbol-coded by experimental condition: glucose (circles),
FOS (squares), L-fucose (diamonds) and control (rectangles). The experimental conditions were used as
supplementary variables as well and could explain 62.9% of the variation.
be involved in sucrose degradation (CRIB_1399-1400) was not significantly regulated
during growth on FOS. However, it should be noted that these genes are located in a cluster
functionally annotated to melibiose metabolism and are most likely regulated by the
transcriptional regulator in this cluster. In addition to the two sucrose degradation clusters,
a transport cluster of unknown function (CRIB_1506-CRIB_1509) was upregulated during
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Figure 3 Heatmap of genes differentially expressed in at least one of the four conditions (≥1.5 log2
(fold change) and q value≤ 0.05). Colour coding by ratio to row mean. Key gene clusters are indicated.
growth on FOS, albeit only significantly when compared to growth on glucose. During
growth in the presence of L-fucose, the gene cluster predicted to be involved in L-fucose
degradation (CRIB_1294-CRIB_1298) was significantly upregulated, including the gene
encoding the corresponding transcriptional regulator (CRIB_1299). An overview of the
main carbohydrate degradation pathways regulated in the different conditions is given
in Fig. 4.
During growth on glucose, L-lactate dehydrogenase (CRIB_684) was significantly
upregulated, albeit not significantly compared to growth on FOS. This enzyme catalyses
the reduction of pyruvate resulting in the production of L-lactate and the reoxidation of
the NADH formed during glycolysis. Only at the time point of 24 h, lactate was observed
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Figure 4 Schematic overview of the pathways involved in degradation of glucose, FOS and L-fucose
in R. ilealis CRIBT. 1A; PTS system glucose-specific EIIA component (CRIB_2018); 1BC, PTS system
glucose-specific EIIBC component (CRIB_2017); 2BC, PTS system sucrose-specific EIIBC component
(CRIB_1461); 3, ß-fructofuranosidase with RDD family protein (CRIB_1459 and CRIB_1460); (continued
on next page. . . )
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Figure 4 (. . .continued)
4, fructokinase (CRIB_152 and CRIB_1458); 5; ABC-type transporter (CRIB_148-CRIB_150); 6,
ß-fructofuranosidase (CRIB_151); 7, glucokinase (CRIB_1849); 8, glucose 6-phosphate isomerase
(CRIB_140); 9, fructose 1,6-bisphosphatase (CRIB_45 and CRIB_2020); 10, 6-phosphofructokinase
; (CRIB_104); 11, fructose-bisphosphate aldolase (CRIB_2223); 12, triosephosphate isomerase
(CRIB_189); 13, glyceraldehyde-3-phosphate dehydrogenase (CRIB_187); 14, phosphoglycerate
kinase; 15, phosphoglycerate mutase (CRIB_1223) and 2,3-bisphosphoglycerate-independent
phosphoglycerate mutase (CRIB_190); 16, enolase (CRIB_191); 17, pyruvate kinase (CRIB_105);
18, L-lactate dehydrogenase (CRIB_684); 19, formate acetyltransferase (CRIB_2141); 20, pyruvate-
flavodoxin oxidoreductase (CRIB_2021); 21, phosphate acetyltransferase (CRIB_2171); 22, acetate
kinase (CRIB_1927); 23, bifunctional aldehyde-alcohol dehydrogenase (CRIB_2231); 24, fatty aldehyde
dehydrogenase (CRIB_2231); 25, L-fucose permease (CRIB_1294); 26, L-fucose isomerase (CRIB_1298);
27, L-fuculokinase (CRIB_1297); 28, L-fuculose phosphate aldolase (CRIB_1297); 29, lactaldehyde
reductase (CRIB_1300); ?, possible mechanisms of external fructose accumulation (external degradation,
or export).
(Table 2). This suggests that at time point∼8–10 h the cells were starting to regenerate NAD
by upregulating this gene. In the presence of L-fucose, NAD+ regeneration is achieved via
the reduction of lactaldehyde to 1,2-propanediol by lactaldehyde reductase (CRIB_1300),
which was upregulated in the presence of L-fucose together with the L-fucose degradation
gene cluster. In the spent medium of L-fucose grown cells, 1,2-propanediol was already
seen at time point ∼8–10 h, whereas no lactate production was observed. Another way to
regenerate NAD+ is to reduce pyruvate to ethanol (Fig. 4). In the presence of both glucose
and FOS, an upregulation was seen for the gene encoding the bifunctional aldehyde/alcohol
dehydrogenase (CRIB_2231), which converts acetyl-CoA to ethanol. However, there were
no samples in which ethanol was measured by HPLC analysis.
During growth on FOS, a small gene cluster (CRIB_601-CRIB_603) that includes a gene
encoding an alternative sigma factor was significantly upregulated. This was also apparent
in the control culture that was inoculated with FOS-preconditioned cells. This suggests
that in the presence of FOS (or its derivatives sucrose or fructose) transcription is also
regulated by RNA polymerase promoter recognition.
Expression and regulation of other environmentally relevant functions
in R. ilealis CRIBT
Noteworthy was the significant upregulation of a gene cluster related to iron transport
(CRIB_892-CRIB-898) during growth on glucose and FOS compared to growth on
L-fucose. The significance of this gene cluster for carbohydrate utilization is not known,
however, several enzymes could be identified in the genome of R. ilealis CRIBT that use
different forms of iron as cofactor, for example the hydrogenases involved in hydrogen
metabolism (Calusinska et al., 2010), several ferredoxins, and the L-threonine dehydratase
(CRIB-426) that was significantly upregulated during growth on L-fucose. As multiple
transporters involved in the transport of iron compounds were predicted, it is possible that
the uptake of iron provides a competitive advantage to other microbes that are dependent
on iron for respiration and other metabolic processes (Kortman et al., 2014).
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Prevalence of R. ilealis in human datasets
R. ilealis was found to be a natural and abundant inhabitant of the rat small intestine,
specifically of the ileum (Gerritsen et al., 2011b). To study its prevalence in humans, 16S
rRNA amplicon sequencing datasets were investigated for the presence of R. ilealis-like
16S rRNA gene sequences. Unfortunately, with respect to composition analysis of human
ileum samples, there is only a limited number of datasets available due to the sampling
difficulties that are the result of the inaccessibility of this part of the intestinal tract. In the
dataset published by Alipour et al. (2016), a paediatric human dataset with samples from
both healthy individuals and inflammatory bowel disease patients, we were not able to
identify any Romboutsia-like 16S rRNA gene sequences. In the dataset published by Gevers
et al. (2014), one of the biggest 16S rRNA gene datasets published to date that includes
samples obtained from multiple gastrointestinal locations (ileal and rectal biopsies and
faecal samples) from both healthy individuals and inflammatory bowel disease patients,
only a limited number of R. ilealis-like 16S rRNA gene sequences could be identified.
In this dataset, the genus Romboutsia could be identified in two samples, with a relative
abundance of 0.1% and 0.2%. In 173 cases the family Peptostreptococcaceae could be
identified in these samples, but it was not possible to differentiate between the genera
Romboutsia and Intestinibacter, due to 100% identity of their rRNA gene sequences in this
region. The Peptostreptococcaceae-positive samples were obtained from both healthy and
diseased individuals (including at least onewith ileal overgrowth and aPeptostreptococcaceae
abundance of 46%). It should be noted that both datasets contain only sequence data from
paediatric ileal biopsy samples and therefore only mucosa-associated microbiota could
be studied limited to a human population <17 years of age, which could explain the low
prevalence of R. ilealis-like 16S rRNA gene sequences. Unfortunately, due to the limited
number of available human datasets and the low prevalence of R. ilealis-like 16S rRNA gene
sequences in ileal biopsy samples, it was not possible to find positive or negative correlations
between prevalence and/or abundance of R. ilealis and specific human diseases.
DISCUSSION
Gerritsen et al. (2011b) have shown by 16S rRNA gene sequence-based analysis that R.
ilealis CRIBT is a dominant member of the small intestine microbiota in rats, especially
in the ileum. The genomic and transcriptomic analysis of R. ilealis CRIBT reported here
provides new insights into the genetic and functional potential of this inhabitant of the small
intestine. Genomic analysis revealed the presence of metabolic pathways for the utilization
of a wide array of simple carbohydrates in addition to a multitude of carbohydrate uptake
systems that included a series of PTS systems, carbohydrate specific ABC transporters,
permeases and symporters. This is in agreement with prior observations by Zoetendal et al.
(2012), who reported that the small intestinal microbiome is enriched for genes involved
in the consumption of simple carbohydrates. However, small disagreements with prior
observations were also observed. An enrichment for amino acid metabolism (Zoetendal et
al., 2012) was not visible in R. ilealis CRIBT, and considerable less COGs could be classified
than for the average small intestinal bacterium (Leimena et al., 2013).
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Since the small intestine is an environment in which environmental conditions change
quickly due to the varying food intake of the host, microorganisms in this environment
must be able to respond rapidly to such changes. As previously mentioned, the high
number of rRNA operons found in the genome of R. ilealis CRIBT is an indication that
this this strain is indeed able to adapt its metabolism quickly in response to changing
conditions, as a high rRNA copy number has been associated with this trait (Klappenbach,
Dunbar & Schmidt, 2000). Considering the small intestinal habitat, we chose to focus on
key pathways involved in the utilization of specific diet- and host-derived carbon sources
by whole-genome transcriptome analysis.
Degradation of FOS and its possible role in cross-feeding
In the intestinal tract, the diet-derived carbohydrates that the host is unable to digest are
important sources of energy for many microbes. In return, the host is dependent on the
degradation of food-derived indigestible component by microbes for the release of certain
essential metabolites (e.g., SCFA). Here we examined the growth of R. ilealis CRIBT on
FOS, a relatively simple oligosaccharide that is indigestible by the host, and the metabolites
that were released. The transcriptome of R. ilealis CRIBT grown on FOS was very similar
to its transcriptome when grown on glucose, a monosaccharide used by the majority of
microbes present in the intestinal tract. This is not surprising considering that glucose
in addition to fructose is one of the two subunits present in FOS. Noteworthy was the
accumulation of fructose in the culture supernatant during growth of R. ilealis CRIBT on
FOS. Based on the genomic analysis there are no apparent reasons why fructose should
not be metabolized as all the necessary metabolic enzymes are present. However, it has
been previously observed that R. ilealis only grows weakly on D-fructose (Gerritsen et al.,
2014). The absence of a fructose-specific transporter, which could be identified in close
relatives that are able to grow on D-fructose, might explain the fructose accumulation
during growth of R. ilealis CRIBT on FOS.
Differential gene expression analysis demonstrated the apparent FOS-induced
upregulation of two separate gene clusters that were predicted to be involved in sucrose
transport and degradation. However, based on the genomic analysis, no apparent pathways
could be identified to be responsible for FOS degradation. A simple explanation for
the observed growth on FOS could be extracellular degradation of FOS, followed by
import of sucrose and/or glucose into the cell. Fructan degradation by extracellular
enzymes is described for other (intestinal) microbes (Van Hijum et al., 2006). The observed
accumulation of fructose during growth of R. ilealis CRIBT on FOS supports the hypothesis
of extracellular degradation. However, no extracellular fructansucrase or glucansucrase
could be predicted. Furthermore, no new candidates for this activity could be identified via
the differential gene expression analysis described here. However, one possible candidate
could be the predicted beta-fructofuranosidase present in the PTS system-containing
sucrose degradation gene cluster. Next to the beta-fructofuranosidase-encoding gene, a
gene was found to which no function could be assigned, but that was predicted to have
a transmembrane region and a domain which could be involved in transport. Given that
both loci overlap by a few nucleotides, and that the overlap is within a homopolymer
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region, it is possible that both loci form one protein due to ribosomal slippage on the
homopolymer (Sharma et al., 2014). This could possibly lead to an external membrane-
bound enzymatically active protein, which would explain the accumulation of fructose.
Future studies withmutant strains might shedmore light on the specific contribution of the
two predicted sucrose degradation gene clusters to the degradation of FOS, or even longer
fructans (e.g., inulin), by R. ilealisCRIBT. Altogether, these results might indicate a possible
role for R. ilealis CRIBT in intestinal cross-feeding networks by releasing D-fructose during
growth on fructans like FOS, which can function as growth substrate for other microbes
or be directly absorbed by the host.
Fucose degradation and its advantages
Besides diet-derived carbohydrates, also host-derived carbohydrates are an important
source of energy for some microbes. Unlike other members of the family Peptostreptococ-
caceae, R. ilealis CRIBT is able to grow on L-fucose, a predominantly host-derived carbon
source (Gerritsen et al., 2014). The transcriptome analysis confirmed the presence of a
functional L-fucose degradation pathway, similar to the pathways previously identified
in other intestinal inhabitants such as E. coli (Baldoma & Aguilar, 1988), Bacteroides
thetaiotaomicron (Hooper et al., 1999) and Roseburia inulinivorans (Scott et al., 2006). By
gene sequence homology a similar pathway was found in Clostridium perfringens and the
more closely related C. sordellii (Fig. S2). L-fucose is a common sugar present within the
intestinal environment, since it is a monosaccharide that is an abundant component of
many N- andO-linked glycans and glycolipids produced bymammalian cells, including the
fucosylated glycans that are found at the terminal positions of mucin glycoproteins (Becker
& Lowe, 2003). Fucosylated mucin glycoproteins are especially found in the (human) ileum
(Robbe et al., 2004; Robbe et al., 2003). For both intestinal commensals and pathogens the
ability to utilize L-fucose has been demonstrated to provide a competitive advantage in
the intestinal environment (Hooper et al., 1999; Stahl et al., 2011). In R. ilealis, all enzymes
for L-fucose degradation are present in one cluster, however, no fucosidase-encoding gene
could be identified, which means that R. ilealis is not able to release L-fucose units from
fucosylated glycans (e.g., mucin) by itself. Hence, in the intestinal environment R. ilealis is
dependent on free L-fucose monosaccharides released by other microbes. Furthermore, a
gene cluster involved in degradation of sialic acid (Almagro-Moreno & Boyd, 2009; Vimr,
2013; Vimr et al., 2004) was predicted from the genome, but no extracellular sialidase could
be identified, which is similar to what has been found for C. difficile (Ng et al., 2013). This
suggests that also for sialic acid, a common residue found in mucin glycoproteins, R.
ilealis CRIBT seems to be dependent on the activity of other microbes. However, this also
suggests that by its ability to use L-fucose and sialic acid monosaccharides, R. ilealis CRIBT
is dependent for these host-derived sugars that are released by the action of extracellular
enzymes of with mucus-degrading microbes like B. thetaiotaomicron or Akkermansia
muciniphila. Besides niche competition with other commensals, fucose utilization may
also be important in niche competition with pathogens. It was recently suggested that
the host is able to regulate fucosylation of its intestinal epithelial cells in response to
pathogen-induced stress and that microbes that are able to use fucose as an energy source
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may contribute to the protection of the host against infections by endogenous pathogens
(Pickard et al., 2014).
Regulation of carbohydrate catabolism
In the intestinal environment R. ilealis CRIBT will encounter a wide array of carbohydrates
that are either continually or transiently present. Prioritization of carbohydrate utilization is
partly achieved at the transcriptional level by the selective expression of genes. The primary
mechanism by which bacteria regulate the utilization of non-preferred carbohydrates in
the presence of preferred carbon sources is known as carbon catabolite repression (CCR),
a hierarchical system for coordinating sugar metabolism (Deutscher, 2008). The fact that,
compared to glucose andFOS, L-fucose is utilized by a pathway that does not directly involve
fructose-1,6-bisphosphate, a key metabolite in the regulation of CCR of Gram-positive
bacteria,made it possible to studyCCRby either glucose or FOS. The transcriptome analysis
suggests that some genes and operons in R. ilealis CRIBT were indeed subject to CCR in
response to the presence of glucose. For example, two gene clusters predicted to be involved
in hexuronate metabolism (CRIB_649-CRIB_652 and CRIB_2244-CRIB_2249), pathways
that make the use of D-glucuronate and D-galacturonates as sole carbon source possible,
were significantly upregulated during growth in the presence of L-fucose compared to
growth on glucose (Table S5). In addition, the gene cluster predicted to be involved in
sialic acid utilization (CRIB_613-CRIB_616) was downregulated in the presence of glucose
as well. Furthermore, when comparing the expression of the gene cluster involved in
L-fucose degradation during growth on glucose relative to the growth in the absence of a
carbon source (control condition), this gene cluster appeared to be under CCR as well, in
the presence of glucose (Table S5). These results suggest that in R. ilealis CRIBT, multiple
gene clusters that are involved in the use of alternative carbon sources are subject to CCR.
Expression and regulation of niche-specific functionalities in
R. ilealis CRIBT
Microbes residing in the intestinal tract have to withstand the harsh environmental
conditions specific for the intestine. In this context, it was interesting that we identified
a urease gene cluster in R. ilealis CRIBT (CRIB_1381-CRIB_1388), expression of which
appeared to be induced in carbon source limiting circumstances. The fact that this gene
cluster was significantly upregulated when grown in the absence of an additional carbon
source compared to growth on glucose, possibly suggests CCR of the urease gene cluster.
However, upregulation of this gene cluster in the absence of an exogenous carbon source
might also be a possible mechanism. Urea in the intestinal tract is derived from the
breakdown of amino acids. Helicobacter pylori is a well-known example where urease
activity contributes to the survival of the bacterium in the acidic environment of the
stomach (Marshall et al., 1990). For some of the urease-positive bacteria, this enzyme has
been shown to act as a virulence factor as it is responsible for urea hydrolysis that leads to
increased pH and ammonia toxicity (Rutherford, 2014). However, for commensal intestinal
bacteria ureases can probably function as colonization factors as well, as they contribute
in general to acid resistance and thereby play a role in gastrointestinal survival (Marshall
et al., 1990). Urea is released into all parts of the intestinal tract via diffusion from the
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blood, but it has been reported that pancreatic excretions and bile are a main route of entry
(Bergner et al., 1986). So far, we have not been able to demonstrate urease activity in R.
ilealis CRIBT (Gerritsen et al., 2014). However, different mechanisms for the expression of
urease have been identified in other microbes: constitutive, inducible by urea, or controlled
by nitrogen source availability (Mobley, Island & Hausinger, 1995). For C. perfringens for
example, the urease activity, which is plasmid borne, was shown to be only expressed in
nitrogen-limiting conditions (Dupuy et al., 1997). The increased urease gene expression
by R. ilealis CRIBT observed in the control condition, in the absence of an additional
carbohydrate, suggests an alternative mechanism for regulation of urease gene expression.
CONCLUSIONS
We are just starting to elucidate the composition and function of the microbial
communities in themammalian small intestine. Recently we have reported the isolation and
characterization of R. ilealis CRIBT from the small intestine of a rat (Gerritsen et al., 2014).
In rats, this specieswas identified to be a dominantmember of the ilealmicrobiota (Gerritsen
et al., 2011b). Here we applied a holistic systems biology approach, involving several fields
of experimental and theoretical biology, to study R. ilealis CRIBT. In conclusion, R. ilealis
CRIBT is a strain that is able to utilize an array of carbohydrates using different and
partially redundant pathways. Its ability to use host-derived sugars that are liberated by
other microbes suggests that R. ilealis CRIBT is dependent on mucus-degrading microbes,
like B. thetaiotaomicron or A. muciniphila. In contrast, it has only limited ability to de novo
synthesize amino acids and vitamins, and hence the organism shows an adaption to a
nutrient-rich environment in which carbohydrates and exogenous sources of amino acids
and vitamins are abundantly available. In addition, we were able to pinpoint potential
mechanisms that might enable this organism to survive in the competitive small intestinal
environment. These mechanisms include bile salt hydrolase and urease enzymes, which
enhance the organism’s ability to handle in particular small-intestinal conditions.
It has to be emphasized that the results presented in this study correspond to one specific
strain and that different strains belonging to the same species could possibly encode for
different functions, including utilisation of specific glycans as previously described by
Crost et al. (2013). However, a deeper investigation of key players in the intestinal tract
like R. ilealis CRIBT and others will lead to a better understanding of how the microbial
communities in us function as a whole. The more we understand how each organism
works, and how they interact, the better we get an insight into these environments and can
predict how nutrition will influence our health and well-being.
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